Advanced primary nonurachal adenocarcinoma of urinary bladder responding to modified FOLFOX6 and capecitabine: a case report

Oxford Medical Case Reports
Frank S Fan, Chung-Fan Yang

Abstract

Careful morphology and immunohistochemistry study can make an accurate differential diagnosis of primary adenocarcinoma of urinary bladder from metastatic lesions involving bladder, especially cancer arising in colon, but there is yet no consensus regarding the standard chemotherapy for advanced adenocarcinoma of urinary bladder among medical oncologists. Sustained response to modified FOLFOX6 (fluorouracil, oxaliplatin plus leucovorin) regimen and oral capecitabine for multiple metastases in a patient with primary nonurachal adenocarcinoma of urinary bladder is presented here as a strong support that the frontline chemotherapy for this infrequent malignant disease is just like what could be chosen for colorectal cancer.

References

May 6, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carmen J AllegraNorman Wolmark
Apr 14, 2011·Nature Reviews. Urology·Minyuen TeoRay S McDermott
Oct 9, 2012·Seminars in Oncology·Arlene Siefker-Radtke
Nov 28, 2013·Urologia Internationalis·A M TatliM Ozdogan
Jun 28, 2014·Chemotherapy·Yutaka YanagiharaMasayoshi Yokoyama
May 17, 2015·Autonomic Neuroscience : Basic & Clinical·K-E Andersson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jim Cassidy
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Robert J Mayer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jim CassidyEric Van Cutsem
The New England Journal of Medicine
Thierry AndréMulticenter International Study of Oxaliplatin/5-Fluorouracil/Leucovorin in the Adjuvant Treatment of Colon Cancer (MOSAIC)
© 2022 Meta ULC. All rights reserved